Foxp3 <sup>+</sup> Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2- STAT3 Pathway in Ovarian Cancer Progression

Foxp3⁺ Tregs drive immunosuppressive macrophage polarization and ovarian cancer progression, highlighting Foxp3 as a potential therapeutic target for EOC treatment.

Authors

Institutions

Publication Details

Journal
Current Gene Therapy
Published
2025-11-03
DOI
https://doi.org/10.2174/0115665232417125251021114250
Citations
4
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
3.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Foxp3 + Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2- STAT3 Pathway in Ovarian Cancer Progression

Zhaohui Xu, Yunfeng Jin, Yi Yang, Hui Chen et al.
4 citations
Current Gene Therapy
Immune cells in cancer
3.19
article

Foxp3 + Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2- STAT3 Pathway in Ovarian Cancer Progression

Zhaohui Xu, Yunfeng Jin, Yi Yang, Hui Chen, Li Li, Bo Guo, Ning Liang
article en
4 citations

Abstract

Foxp3⁺ Tregs drive immunosuppressive macrophage polarization and ovarian cancer progression, highlighting Foxp3 as a potential therapeutic target for EOC treatment.

Current Gene TherapyVol. 26(2)
Nantong University (CN), Affiliated Hospital of Nantong University (CN)
Openalex Percentile: Top 7%
Immune cells in cancer
3.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Foxp3 <sup>+</sup> Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2- STAT3 Pathway in Ovarian Cancer Progression — Zhaohui Xu, Yunfeng Jin, et al. · Current Gene Therapy (2025) | TGRS Research Map | TGRS